PT2399, CAS [[1672662-14-4]]
Artikelnummer:
BYT-ORB1309175
Produktübersicht
Artikelname:
PT2399, CAS [[1672662-14-4]]
Artikelnummer:
BYT-ORB1309175
Hersteller Artikelnummer:
orb1309175
Alternativnummer:
BYT-ORB1309175-1,BYT-ORB1309175-5,BYT-ORB1309175-10,BYT-ORB1309175-25,BYT-ORB1309175-50,BYT-ORB1309175-100
Hersteller:
Biorbyt
Kategorie:
Biochemikalien
Alternative Synonym:
Inhibitor, inhibit, Hypoxia-inducible factors, HIFs, HIF-PH, HIFProlylHydroxylase, HIF-2alpha, HIF/HIFProlylHydroxylase, HIF/HIF ProlylHydroxylase, HIF/HIF Prolyl-Hydroxylase, HIF, HIF ProlylHydroxylase, HIF Prolyl-Hydroxylase, PT2399, PT-2399, PT 2399
Produktbeschreibung
PT2399 is a selective, orally bioavailable HIF-2alpha inhibitor that disrupts its dimerization with HIF-1beta. It demonstrates significant antitumor efficacy in preclinical in vivo models, making it a valuable chemical probe for researching hypoxia signaling pathways in renal cell carcinoma and other cancers.
Produkteigenschaften
Molekulargewicht:
419.32
Reinheit:
99.45% (May vary between batches)
CAS Nummer:
[1672662-14-4]
Formel:
C17H10F5NO4S
Target-Kategorie:
HIF/HIF Prolyl-Hydroxylase,HIF
Anwendungsbeschreibung
Anwendungsbeschreibung:
Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (11.92 mM),DMSO:262.5 mg/mL (626.01 mM)
